Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer
Open Access
- 30 April 2000
- journal article
- Published by Elsevier in The Breast
- Vol. 9 (2), 72-77
- https://doi.org/10.1054/brst.2000.0135
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Genetic testing in breast/ovarian cancer (BRCA1) familiesThe Lancet, 1995
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Predictive testing for germline mutations in the p53 gene: Are all the questions answered?European Journal Of Cancer, 1993
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancerBritish Journal of Cancer, 1988
- The accuracy of patient reports of a family history of cancerJournal of Chronic Diseases, 1985